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Abstract
Background and Aim: Teat disinfection is an important tool in reducing the incidence of bovine mastitis. Identifying the 
potential mastitis-causing bacterial species in milk can be the first step in choosing the correct teat disinfectant product. The 
objective of this study was to screen commercial teat disinfectants for inhibition against mastitis-associated bacteria isolated 
from various types of milk samples.
Materials and Methods: Twelve commercially available teat disinfectant products were tested, against 12 mastitis-
associated bacteria strains isolated from bulk tank milk samples and bacterial strains isolated from clinical (n=2) and 
subclinical (n=3) quarter foremilk samples using the disk diffusion method.
Results: There was a significant variation (7-30 mm) in bacterial inhibition between teat disinfection products, with products 
containing a lactic acid combination (with chlorhexidine or salicylic acid) resulting in the greatest levels of bacterial 
inhibition against all tested bacteria (p<0.05).
Conclusion: In this study, combined ingredients in teat disinfection products had greater levels of bacterial inhibition 
than when the ingredients were used individually. The disk diffusion assay is a suitable screening method to effectively 
differentiate the bacterial inhibition of different teat disinfectant products.
Keywords: bacteria, disk diffusion, mastitis, teat disinfectant.
Introduction
Mastitis is an inflammatory process occur-
ring in the mammary gland that can be subclinical 
or clinical [1], and intramammary infections (IMIs) 
refers to the presence of an infectious organism in 
the udder [2]. Mastitis can affect milk quality, ani-
mal health and welfare [3] and is one of the main 
milk production and economic problems facing 
the global dairy industry [4]. Many factors such as 
stage of lactation, herd size, housing and bedding 
type, and hygiene during milking can influence the 
occurrence of a new IMI [5]. The implementation of 
effective control programs on farms, such as teat dis-
infection and antimicrobial treatment of infections, is 
essential to reduce the effect of mastitis on the dairy 
industry [6,7]. Mastitis pathogens can be classified as 
either environmental or contagious [3], with the main 
mastitis-causing bacteria identified in clinical and 
subclinical samples in Ireland being Staphylococcus 
aureus, Streptococcus agalactiae, Escherichia coli, 
and Streptococcus uberis [1].
Teat disinfectants play an important role in a 
mastitis control program [8]. Previous studies have 
shown that both pre- and post-milking disinfection 
can reduce the incidence of clinical mastitis caused by 
contagious bacteria by 50% [9,10] and environmental 
bacteria by 24% [8]. Many studies have shown iodine 
to be effective against a wide range of mastitis-causing 
bacteria [8,11-13]. However, the use of iodine-based 
products can result in high iodine concentrations in 
milk, which may concern infant formula manufac-
turers [14]. There is now a wide range of alternative 
teat disinfectants available containing different active 
ingredients, but with limited information available on 
their ability to inhibit bacterial growth. Many of these 
teat disinfectant products contain a mixture of different 
ingredients.  The combining of these ingredients can 
be problematic [7,15] as manufacturers must ensure 
that disinfection is maximized while skin irritation is 
minimized. Therefore, the active ingredient, pH, skin 
conditioners, and surfactant must be balanced to cre-
ate an effective teat disinfectant product [15]. Bulk 
tank milk (BTM) analysis can determine milk quality 
and the presence of mastitis pathogens [16]. It can be 
convenient, low cost, and fast [17] and can provide 
information regarding on-farm hygiene conditions 
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during milk production [18]. However, analysis of 
individual cow foremilk samples is more precise for 
monitoring udder health and pathogen diagnosis [19]. 
Pathogen type and numbers of bacteria in milk can 
differ between farms [20]. Traditional microbial and 
molecular methods can be used in conjunction or 
separately to identify mastitis-causing bacteria [21]. 
It is important to evaluate teat disinfectant products 
against mastitis-causing bacteria identified in the 
environment where these products will be used. The 
National Mastitis Council experimental challenge and 
natural exposure protocols are used for demonstrating 
field efficacy in reducing new IMI, but unfortunately, 
these tests can be time consuming and expensive. 
However, the germicidal effectiveness of teat disin-
fectants can be assessed using laboratory tests against 
a broad range of pathogens of interest [22]. At pres-
ent, in the European Union, a standard method used 
to evaluate teat disinfectant products, before they can 
be sold commercially, is the BS EN 1656 [23,24]. To 
meet the requirements of this standard, the product 
tested with this standard must demonstrate at least a 
105 log reduction in viable counts of the test species 
within 5 min. The disk diffusion assay, on the other 
hand, has the potential to quantitatively assess the 
ability of a large range of teat disinfectant products 
to inhibit bacterial growth [25] at a laboratory scale 
within a short time period.
Therefore, the objective of this study was to 
screen commercially available teat disinfectant prod-
ucts by determining the ability of these products to 
inhibit the growth of bacteria, isolated from BTM, 
and subclinical and clinical quarter foremilk samples, 
using the disk diffusion method.
Materials and Methods
Ethical approval
Approval from the Institutional Animal Ethics 
Committee to carry out the current study was not 
required as no invasive procedure on the animals was 
performed.
Sample collection
BTM samples were collected from 22 randomly 
selected dairy farms in one geographical region 
(Southeast of Ireland) that was willing to participate 
in the study. The milk was produced during October 
when the cows were managed outdoors and grazing 
on pastures. The milk samples (50 mL) were col-
lected from the bulk tanks of these 22 dairy farms. 
Individual quarter foremilk samples were separately 
collected from clinically and subclinically infected 
quarters from three research farms. All of the samples 
were held at 4°C until analysis for bacterial identifi-
cation and total bacterial counts (TBCs), which were 
conducted within 3-4 h of collection.
Bacterial identification
The milk samples were serially diluted in Maximum 
Recovery Diluent (MRD) (Oxoid, Basingstoke, UK). 
Using the spread plate method, 100 μl of an appropriate 
dilution was transferred onto Milk Plate Count Agar 
(Oxoid, Basingstoke, UK) plates, which were incubated 
at 37°C for 24 h. 22 bacterial isolates displaying the 
morphology of pathogens associated with mastitis were 
then taken from each plate and streaked for isolation 
and purification. Once isolated, these bacterial cultures 
were Gram stained and bacterial identification was car-
ried out using biochemical tests (catalase and oxidase 
tests), growth at various temperatures (25°C and 35°C), 
and on various types of agars [25] and using 16S rDNA 
sequencing of products generated by polymerase chain 
reaction (PCR) [21,26].
From 22 bacterial isolates, 17 bacterial iso-
lates which displayed morphology similar to bacte-
ria associated with mastitis were subjected to DNA 
extraction and PCR identification. DNA extraction 
was carried out using the GenElute Bacterial Genomic 
DNA kit (Sigma-Aldrich, Dublin, Ireland). The pro-
cedure was conducted according to the manufac-
turer’s instructions, with the isolated DNA samples 
suspended and stored in the elution solution (10 mM 
Tris-HCl, 0.5 mM EDTA, pH 9.0) provided in the kit. 
The PCR products were cleaned using AMPure XP 
beads. The primers used for the reaction were UniF 
(5′-AGAGTTTGATCCTGGCTCAGG-3′) and UniR 
(5′-ACGGCAACCTTGTTACGAGT-3′) and 16S 
rDNA gene sequencing was completed by GATC bio-
tech (London, UK). These sequences were compared 
with those available in the GenBank database using the 
BLAST program available from the National Center 
for Biotechnology Information (NCBI) (http://www.
ncbi.nlm.nih.gov). If species-specific sequences in 
the database matched the query sequence with ≥99% 
identity, then the query sequence was determined to 
come from that species [26].
TBCs were performed by serially diluting the 
milk samples using MRD. Then, 1 mL of the solution 
was pipetted onto separate Petrifilm Total Aerobic 
Count plates (3M, St. Paul, MN, USA), which were 
incubated at 32°C for 48 h and bacteria were counted 
using a 3M Petrifilm Plate Reader.
Teat disinfectant information
Twelve commercially available teat disinfectant 
products, with different active ingredients of varying 
concentrations, were tested against the isolates iden-
tified above. An iodine product was chosen as a pos-
itive control, as iodine has been previously shown to 
effectively inhibit mastitis-related bacteria [11,25]. 
The disinfectants used were predominately ready-
to-use products apart from two products (the control 
and ammonium lauryl sulfate [product number 6]) 
which were concentrated products requiring dilution 
to a usable concentration (Table-1). These products 
were diluted, using sterile deionized water, accord-
ing to the manufacturer’s recommendation, to avoid 
possible issues with water hardness or contaminated 
water. The disinfectant products used were suitable 
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for both pre- and post-milking teat disinfection, with 
the exception of two products (the control and prod-
uct number 2), which were recommended only for 
post-milking disinfection.
Disk diffusion assay
The teat disinfectant susceptibility test was car-
ried out using the disk diffusion assay to determine 
the ability of the teat disinfectant products to inhibit 
bacterial growth. 17 bacterial isolates from species 
associated with mastitis, isolated from BTM (n=12), 
subclinically infected quarter foremilk samples (n=3), 
and clinically infected quarter foremilk samples (n=2) 
were grown on separate Mueller-Hinton (MH) agar 
(Sigma-Aldrich) plates with various filter paper disks 
impregnated with teat disinfectant (three filter paper 
disks per plate).
All agars and diluents used in this study were 
prepared according to manufacturers’ recommenda-
tions, with 10 mL of MH agar being poured to a depth 
of 4 mm. The test inoculum was prepared from a pure 
culture grown on MH agar for 16 h. To prepare the 
inoculum, a loopful of the organisms was suspended 
in MRD and the turbidity of the suspension adjusted to 
a 0.5 McFarland standard (BioMerieux, UK) (approx-
imately 108 CFU/mL) [27,28]. Each bacterial suspen-
sion was used within 15 min of preparation. Using the 
spread plate method, 100 μl of the bacterial suspension 
was spread onto MH agar using a sterile “L”-shaped 
spreader and left to dry for 10-15 min. While drying, 
blank 6 mm antibiotic paper disks (Cruinn, Dublin, 
Ireland) were left to soak in the test disinfectant for 
30 s. The disks were placed onto the agar using a ster-
ile forceps, ensuring the entire disk was touching the 
agar. The plates were then incubated at 37°C for 24 h. 
After incubation, the zones of inhibition were mea-
sured using an electronic caliper (Mitutoyo Digimatic, 
RS digital caliper 600/880).
After completion of the disk diffusion test on the 
12 teat disinfectant products, specific products which 
resulted in large zones of inhibition and small zones of 
inhibition were subjected to testing under the BS EN 
1656 standard to determine if those products met the 
required 105 log reduction.
Statistical analysis
Twelve bacterial isolates from BTM samples 
found to be associated with mastitis and five masti-
tis-causing bacterial isolates from quarter foremilk 
samples (subclinically infected quarter foremilk sam-
ples [n=3] and clinically infected quarter foremilk 
samples [n=2]) were used in the study. The experi-
ments were independently repeated on three occa-
sions, with three plate replicates for each experimental 
data point giving a mean result for each experimental 
batch.
Statistical analysis was performed using SAS 
for Windows, version 9.4 (SAS Institute Inc., Cary, 
NC, USA). The results were analyzed using PROC 
GLIMMIX. Pair-wise comparisons were adjusted 
for multiplicity effect using simulation procedures 
to adjust P-values. Residual checks were made to 
ensure that assumptions of the analysis were met. The 
LSMEANS statement in PROC GLIMMIX was used 
to differentiate statistical differences. The zones of 
inhibition for the bacteria isolated from BTM and the 
bacteria isolated from quarter foremilk samples were 
analyzed using two models (one for each milk sample 
source). Both models included the zones of inhibition 
as a dependent variable and product and bacteria as 
independent variables.
Results
The 12 mastitis-associated isolates, identified 
from BTM samples using biochemical tests and 
16S rDNA sequencing, were placed into one of two 
Table-1: Test teat disinfectant product code and active ingredient, as declared by the manufacturer.
Product 
number
Active ingredients Manufacturer
Control Iodine (0.50% w/w)1 Agroserve, Wiltshire, United Kingdom.
1 Lactic acid (5.00% w/w) and chlorhexidine 
digluconate (0.30% w/w)2
Ark Farm Innovations, Gorey, Wexford, Ireland.
2 Chlorhexidine (0.45% w/w)2 Diversey Hygiene Sales Limited, Finglas, Dublin 11, 
Ireland.
3 Chlorhexidine digluconate (0.60% w/w)2 Diversey Hygiene Sales Limited, Finglas, Dublin 11, 
Ireland.
4 Lactic acid (0.25% w/w) and salicylic acid (Not stated)2 Kilco International, Dumfries and Galloway, United 
Kingdom.
5 Lactic acid (2.50% w/w) and chlorhexidine 
digluconate (0.30% w/w)2
Biocel Ltd., Little Island, Cork, Ireland.
6 Ammonium lauryl sulfate (3.10% w/w)1 Bimeda, Tallaght, Dublin, Ireland.
7 Lactic acid (1.93% w/w) and chlorhexidine 
digluconate (0.20% w/w)2
Kilco International, Dumfries and Galloway, United 
Kingdom.
8 Lactic acid (2.40% w/w)2 GEA Farm Technologies, Bönen, Germany
9 Diamine (0.60% w/w)2 Milk Solutions Ltd., Kilworth, Cork, Ireland.
10 Chlorine dioxide and didecyldimethylammonium 
chloride (0.04% w/w)2
Hilltop Eng. and Agri Supplies, Enniskillen, 
Fermanagh, N. Ireland,
11 Lactic acid (2.50% w/w) and salicylic acid (0.10% w/w)2 Hypred SAS, 35803 DINARD Cedex, France.
( ) Ingredients as indicated on product label, 1Concentrate products, 2Ready-to-use products
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groups: (1) Environmental bacteria which included; 
Enterococcus faecalis, Hafnia alvei, Serratia marc-
escens, Serratia liquefaciens, Aerococcus viridans, 
and Lactococcus lactis and (2) staphylococcal bac-
teria which included; Staphylococcus chromogenes, 
Staphylococcus devriesei, Staphylococcus epidermis, 
Staphylococcus haemolyticus, Staphylococcus homi-
nis, and Staphylococcus xylosus (Table-2).
From the different clinical and subclinical sam-
ples, five mastitis-associated isolates were identified. 
Three S . aureus strains (S. aureus 324, S. aureus 308, 
and S. aureus 311) were isolated from subclinical 
quarter foremilk samples. In addition, one S. uberis 
and one E. coli were identified in clinical quarter 
foremilk samples.
Inhibiting the growth of bacteria identified from BTM 
samples
The disk diffusion method established the ability 
of the teat disinfectant products to inhibit the growth 
of the bacterial species identified from BTM and quar-
ter foremilk samples. The TBC for BTM ranged from 
500 to 465,000 CFU/mL, with farms with high TBC 
values (>98,517 CFU/mL) having more environmen-
tal bacteria than the farms with lower TBC values. 
The farms in which the described staphylococcal spe-
cies were recovered had an overall average TBC of 
17,070 CFU/mL (Table-2).
Environmental bacterial group
Within the group of environmental bacteria, 
H. alvei, S. liquefaciens, and S. marcescens were the 
most resistant bacteria on average across all teat dis-
infectants, while L. lactis was the most susceptible 
bacteria to all tested teat disinfectants (p<0.05). Overall, 
the product containing a combination of lactic acid and 
salicylic acid (product number 11) had the greatest 
bacterial inhibitions against all environmental bacte-
ria. This product resulted in an overall average (±SE) 
zone of inhibition of 21.3 (±0.65) mm. In comparison, 
the control resulted in an overall average zone of inhi-
bition of 15.5 (±0.46) mm, which was less than lactic 
acid and salicylic acid (product 11) (p<0.05). The zones 
of inhibition of teat disinfectant products compared to 
the iodine control against each environmental bacterial 
strain are shown in Table-3. The product containing 
ammonium lauryl sulfate (product number 6) had sig-
nificantly smaller results of bacterial inhibition against 
environmental bacteria compared to all teat disinfec-
tants, resulting in an average zone of inhibition of 11.8 
(±0.43) mm across all environmental bacteria (Table-3).
Staphylococcal species group
Within the group of staphylococcal bacteria, 
S. haemolyticus, S. Xylosus, and S. devriesei were the 
most resistant bacteria, while S. hominis, S. Epidermis, 
and S. chromogenes were the most susceptible bac-
teria. Overall, within the group of staphylococcal 
bacteria, the product which contained a combination 
of lactic acid and salicylic acid (product number 11) 
resulted in the largest zones of inhibition (average 
zones of inhibition of 25.3 [±0.85] mm) in comparison 
to the control which had an overall average zone of 
inhibition of 17.7 (±0.63) mm for all staphylococcal 
bacteria (p<0.05). The zones of inhibition of test teat 
disinfectant products compared to the iodine control 
for each staphylococcal bacterial strain are displayed 
in Table-4. However, the product containing ammo-
nium lauryl sulfate resulted in smaller zones of inhibi-
tion, resulting in an overall average zone of inhibition 
of 15.8 (±0.52) mm (Table-4). Overall, environmental 
bacteria were more resistant than staphylococcal bac-
teria to all teat disinfectant products (p<0.05).
Inhibiting the growth of bacteria identified from clin-
ical and subclinical quarter foremilk samples
The comparison of test teat disinfectant products 
to the iodine control for the quarter foremilk isolates is 
shown in Table-5. E. coli was the most resistant bacte-
ria with S. uberis being the most susceptible to the teat 
disinfectants tested (p>0.05).
The zones of inhibition of teat disinfectant prod-
ucts were not significantly different between the three 
different S. aureus isolates identified from subclinical 
quarter foremilk samples (p>0.05). Products contain-
ing chlorine dioxide (product number 10) and chlor-
hexidine (product number 2) resulted in the largest 
zones of inhibition for all three isolates of S. aureus. 
These products resulted in average zones of inhibi-
tion of 24.3 (±1.10) and 21.0 (±0.56) mm, respec-
tively. In comparison, diamine (product number 9) 
had the smallest result of bacterial inhibition for all 
three isolated S. aureus, resulting in an average zone 
of inhibition of 15.0 (±0.50) mm. The average zones 
Table-2: Mastitis-associated bacterial isolates identified 
from BTM samples with isolate numbers and TBC for each 
BTM sample.
Bacterial species BTM sample code  
(number of isolates)
TBC 
 (CFU/mL)
Environmental
Aerococcus viridans 52 (1) 2,000
Enterococcus 
faecalis
26 (1) 465,000
Hafnia alvei 33 (1) 29,000
Lactococcus lactis 45 (1) 7,050
Serratia liquefaciens 10 (1) 9,550
Serratia marcescens 4 (1) 78,500
Staphylococcal 
species
Staphylococcus 
chromogenes
10 (1) 9,550
Staphylococcus 
devriesei
5 (1) 4,400
Staphylococcus 
epidermis
55 (1) 67,000
Staphylococcus 
haemolyticus
14 (1) 4,350
Staphylococcus 
hominis
55 (1) 67,000
Staphylococcus 
xylosus
22 (1) 500
Total number of isolates associated with mastitis=12. 
BTM=Bulk tank milk, TBC=Total bacterial count
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of inhibition across all three S. aureus strains are 
presented in Figure-1a.
The products with the greatest amount of bacte-
rial inhibition against E. coli contained a combination 
of lactic acid and chlorhexidine (product number 5) 
and lactic acid and salicylic acid (product number 11). 
These products resulted in the greatest average zones 
of inhibition of 20.0 (±0.70) and 19.0 (±0.51) mm, 
respectively. In comparison, a product containing 
ammonium lauryl sulfate (product number 6) resulted 
in an average zone of inhibition of 12.0 (±1.60) mm 
against E. coli (Table-5).
Lactic acid and salicylic acid (product number 11) 
were the most effective product against S. uberis. 
This product resulted in an average zone of inhibi-
tion of 25.0 (±0.90) mm, in comparison to the control, 
which showed an average zone of inhibition of 20.0 
(±0.6) mm (p<0.05). Similarly, to E. coli and S. aureus 
isolates, a product containing ammonium lauryl sul-
fate (product number 6) was the least effective against 
S. uberis, resulting in an average zone of inhibition of 
16.0 (±0.30) mm, compared to all of the teat disinfec-
tants tested (p<0.05) (Table-5). The zones of inhibition 
for E. coli and S. uberis are presented in Figure-1b.
Evaluation of products using the BS EN 1656 standard
At the conclusion of the disk diffusion study, 
two teat disinfectant products were selected for eval-
uation using the BS EN 1656 standard. A disinfec-
tant that generally produced large zones of inhibition 
(product 1) and one that was typically resulted in 
smaller zones (product 9) was selected for evaluation. 
Products 1 and 9 had log reductions greater than that 
required for this standard (105).
Discussion
Of the bacteria isolated from BTM samples, 
environmental bacteria were more resistant to all teat 
disinfectant products than staphylococcal isolates, 
which is similar to other studies [8,29]. A previous 
study showed that teat disinfectant products (hydro-
gen peroxide), chlorine dioxide, 1% w/w iodophor, 
and 0.5% w/w iodophor) resulted in higher log reduc-
tions against staphylococcal isolates than E. coli [29].
Ten of the teat disinfectant products tested 
resulted in higher levels of bacterial inhibition against 
the bacteria isolated from BTM compared to the con-
trol. The majority of teat disinfectant products were 
significantly different from each other (p<0.05), 
with products containing a mix of lactic acid (2.5-
5% w/w) and chlorhexidine (0.3% w/w) (product 
numbers 1 and 5) and a mix of lactic acid (2.5% w/w) 
and salicylic acid (0.1% w/w) (product number 11) 
resulting in the greatest levels of bacterial inhibition 
against both environmental and staphylococcal spe-
cies bacteria. The previous studies have shown these 
ingredients to be effective in the control of IMIs. 
A chlorhexidine product (0.35% w/w) was previously 
shown to reduce IMIs caused by major mastitis bac-
teria by 50% compared to non-disinfected teats [30]. Ta
b
le
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Lactic acid, when used as an activator to create a chlor-
ous acid post-milking teat disinfectant, was shown to 
reduce new IMIs caused by S. aureus and S. agalac-
tiae by 69% and 35%, respectively [31]. Similarly, a 
sodium chlorite-lactic acid-based teat disinfectant had 
a higher percent log reduction compared to an iodine-
based teat disinfectant [32].
The bacteria isolated from individual quarter 
foremilk samples were similar to those identified in 
a previous study that created a list of bacterial patho-
gens responsible for clinical and subclinical mastitis 
in dairy herds in Ireland over a full lactation [1]. The 
most common mastitis-causing pathogens identified 
from quarter foremilk samples were E. coli, S. aureus, 
S. uberis, Streptococcus species, and coagulase-nega-
tive Staphylococci, with S. aureus accounting for 60% 
of all mastitis cases [1].
A difference in teat disinfectant ability to inhibit 
the growth of bacteria was observed against all bac-
terial species isolated from clinical and subclinical 
quarter foremilk samples, with E. coli being the most 
resistant bacteria to the teat disinfectant products 
tested. Similarly, a wide range of teat disinfectants 
(iodine, chlorhexidine, sodium hypochlorite, quater-
nary ammonium, bronopol, and iodophor) resulted in 
significantly lower log reductions for E. coli and high 
log reductions for S. aureus [33]. In this study, lactic 
acid combined with salicylic acid (product number 11) 
resulted in the largest zones of inhibition against both 
E. coli and S. uberis. Similarly, a sodium chlorite-lac-
tic acid teat disinfectant was highly effective against 
E. coli [32]. However, chlorine dioxide (product num-
ber 10) resulted in large zones of inhibition against 
all three S. aureus isolates, compared to the control. 
Chlorine dioxide has been shown to be one of the most 
effective products against S. aureus [29] and most 
effective in pre-milking cleaning regimes [29,34,35]. 
A chlorine dioxide teat disinfectant was also found to 
be comparable to an iodine-based teat disinfectant [36].
For both BTM and quarter foremilk sample iso-
lates, products containing 5% w/w lactic acid and 
0.3% w/w chlorhexidine (product number 1), 2.5% w/w 
lactic acid and 0.3% w/w chlorhexidine (product num-
ber 5), and 2.5% w/w lactic acid and 0.1% w/w sal-
icylic acid (product number 11) may have achieved 
large zones of inhibition due to the levels of active 
ingredient. This may be due to the high concentration 
and combination of the active ingredients as a product 
containing a lower lactic acid content (0.25% w/w) 
(product number 4), resulted in smaller zones of inhibi-
tion compared to these products. This may suggest that 
the levels of active ingredients as applied in the prod-
ucts and when active ingredients are combined rather 
than when used individually may result in better bac-
terial inhibition. A previous study found that 0.1% w/w 
chlorhexidine teat disinfectant was not effective against 
S. aureus and S. agalactiae, due to a low germicide 
concentration and recommended the use of 0.5% w/w 
chlorhexidine [37]. However, 0.35% w/w chlorhexi-
dine teat disinfectant resulted in over a 50% reduction 
of S. aureus [30]. Furthermore, products containing one 
active ingredient, such as chlorhexidine (product num-
bers 2 and 3) or lactic acid (product number 8), did not 
attain large zones of inhibition as products with com-
bined active ingredients.
The disk diffusion assay used in this study has 
previously been used to evaluate a range of anti-
biotics [38,39] and a teat disinfectant product of vary-
ing concentration [25]. Procedures recommended 
by CLSI [28], for the application of this method, 
Figure-1: The average zone of inhibition (mm) for teat disinfectant products against bacteria isolated from (a) subclinical 
quarter foremilk samples (average of the three Staphylococcus aureus isolates) and (b) clinical quarter foremilk samples 
(Escherichia coli and Staphylococcus uberis). Error bars indicate SE. Teat disinfectant: C=Control (0.5% iodine), 1=Lactic 
acid and chlorhexidine, 2=Chlorhexidine, 3=Chlorhexidine, 4=Lactic acid and salicylic acid, 5=Lactic acid and chlorhexidine, 
6=Ammonium lauryl sulfate, 7=Lactic acid and chlorhexidine, 8=Lactic acid, 9=Diamine, 10=Chlorine dioxide, and 
11=Lactic acid and salicylic acid.
a
b
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were used and adapted in this study to determine the 
bacterial inhibition of a wide range of teat disinfec-
tants. The disk diffusion method can differentiate 
the bacterial inhibition of teat disinfectant products, 
whereas the BS EN 1656 aims to achieve at least a 
105 log reduction. The teat disinfectant products used 
in this study are commercially available and have all 
previously undergone testing using the BS EN 1656 
standard and would have achieved the required log 
reduction. In this study, two products (one with small 
and one with large zones of inhibition) were also eval-
uated using BS EN 1656, and both products achieved 
the required log reduction.
The disk diffusion method allows for laboratory 
screening of a large number of teat disinfectant prod-
ucts within a short time period against a bacterial spe-
cies or strain of interest. Unfortunately, this method is 
limited in how it tests the product as it does not take 
into account contact time of the teat disinfectant, the 
reduction of the bacterial load on the teat skin surface, 
or the products true efficacy in reducing the number 
of new IMIs. In comparison, naturally occurring and 
experimental challenge methods can test the efficacy 
of a teat disinfectant product as the reduction of new 
IMIs and the reduction of teat skin bacteria can be 
recorded. However, there is considerable expense and 
time associated with such studies.
The results showed that there is a range of alter-
native teat disinfectant products available which 
reduce bacterial growth comparable to iodine-based 
products. Field trials would be required to fully deter-
mine the products efficacy and ability to reduce IMIs.
Conclusion
This study gives an indication of the ability of 
teat disinfectant products to inhibit the growth of mas-
titis-causing bacteria identified in Irish milk samples. 
The three products which had the greatest levels of 
bacterial inhibition evaluated against the most preva-
lent mastitis-causing bacteria (S. aureus and S. uberis) 
in Irish herds contained a combination of lactic acid 
(2.5 or 5% w/w) and chlorhexidine (0.3% w/w) or sal-
icylic acid (0.1% w/w). This may suggest that some 
active ingredients may work more successfully when 
combined with other active ingredients, rather than 
when used individually. The levels of lactic acid in 
combination products may also be important as levels 
of 2.5% w/w, or greater, showed greater bacterial inhi-
bition compared to products with lower levels of lactic 
acid. The disk diffusion assay is a suitable screening 
method to effectively differentiate the bacterial inhibi-
tion of different teat disinfectant products.
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